75 related articles for article (PubMed ID: 11422039)
21. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.
Di Zenzo G; Di Lullo G; Corti D; Calabresi V; Sinistro A; Vanzetta F; Didona B; Cianchini G; Hertl M; Eming R; Amagai M; Ohyama B; Hashimoto T; Sloostra J; Sallusto F; Zambruno G; Lanzavecchia A
J Clin Invest; 2012 Oct; 122(10):3781-90. PubMed ID: 22996451
[TBL] [Abstract][Full Text] [Related]
22. Focus on pemphigus treatment publications: A bibliometric and visual analysis (1992-2022).
Wang X; Huang C; Li W; Hong Y
Heliyon; 2024 Apr; 10(7):e28462. PubMed ID: 38590872
[TBL] [Abstract][Full Text] [Related]
23. IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.
Koneczny I; Tzartos J; Mané-Damas M; Yilmaz V; Huijbers MG; Lazaridis K; Höftberger R; Tüzün E; Martinez-Martinez P; Tzartos S; Leypoldt F
Front Immunol; 2022; 13():834342. PubMed ID: 35401530
[TBL] [Abstract][Full Text] [Related]
24. The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab.
Golinski ML; Lemieux A; Maho-Vaillant M; Barray M; Drouot L; Schapman D; Petit M; Hertl M; Boyer O; Calbo S; Joly P; Hébert V
Front Immunol; 2022; 13():849790. PubMed ID: 35371083
[TBL] [Abstract][Full Text] [Related]
25. Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease.
Cho A; Caldara AL; Ran NA; Menne Z; Kauffman RC; Affer M; Llovet A; Norwood C; Scanlan A; Mantus G; Bradley B; Zimmer S; Schmidt T; Hertl M; Payne AS; Feldman R; Kowalczyk AP; Wrammert J
Cell Rep; 2019 Jul; 28(4):909-922.e6. PubMed ID: 31340153
[TBL] [Abstract][Full Text] [Related]
26. Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases.
Li Z; Jing K; Li S; Feng S
Postepy Dermatol Alergol; 2018 Aug; 35(4):338-343. PubMed ID: 30206444
[TBL] [Abstract][Full Text] [Related]
27. Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus Vulgaris.
Ellebrecht CT; Mukherjee EM; Zheng Q; Choi EJ; Reddy SG; Mao X; Payne AS
Cell Rep; 2018 Aug; 24(9):2370-2380. PubMed ID: 30157430
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin E-Mediated Autoimmunity.
Maurer M; Altrichter S; Schmetzer O; Scheffel J; Church MK; Metz M
Front Immunol; 2018; 9():689. PubMed ID: 29686678
[TBL] [Abstract][Full Text] [Related]
29. Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.
Pollmann R; Schmidt T; Eming R; Hertl M
Clin Rev Allergy Immunol; 2018 Feb; 54(1):1-25. PubMed ID: 29313220
[TBL] [Abstract][Full Text] [Related]
30. Blocking RhoA/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1/NOD2-mediated NF-κB pathway.
Liang J; Zeng X; Halifu Y; Chen W; Hu F; Wang P; Zhang H; Kang X
Mol Cell Biochem; 2017 Dec; 436(1-2):151-158. PubMed ID: 28608226
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of molecular diagnostics in pemphigus and bullous pemphigoid: comparison of commercial and modified mosaic indirect immunofluorescence tests as well as enzyme-linked immunosorbent assays.
Gornowicz-Porowska J; Seraszek-Jaros A; Bowszyc-Dmochowska M; Kaczmarek E; Pietkiewicz P; Bartkiewicz P; Dmochowski M
Postepy Dermatol Alergol; 2017 Feb; 34(1):21-27. PubMed ID: 28261028
[TBL] [Abstract][Full Text] [Related]
32. Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease.
Qian Y; Culton DA; Jeong JS; Trupiano N; Valenzuela JG; Diaz LA
Autoimmun Rev; 2016 Sep; 15(9):923-30. PubMed ID: 27396816
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of NLRP1 and IPAF are related to oral pemphigus vulgaris pathogenesis.
Shamsabadi RM; Basafa S; Yarahmadi R; Goorani S; Khani M; Kamarehei M; Hossein Kiani A
Inflammation; 2015 Feb; 38(1):205-8. PubMed ID: 25342284
[TBL] [Abstract][Full Text] [Related]
34. The desmosome and pemphigus.
Waschke J
Histochem Cell Biol; 2008 Jul; 130(1):21-54. PubMed ID: 18386043
[TBL] [Abstract][Full Text] [Related]
35. T cell control in autoimmune bullous skin disorders.
Hertl M; Eming R; Veldman C
J Clin Invest; 2006 May; 116(5):1159-66. PubMed ID: 16670756
[TBL] [Abstract][Full Text] [Related]
36. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
[TBL] [Abstract][Full Text] [Related]
37. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.
Nagel A; Lang A; Engel D; Podstawa E; Hunzelmann N; de Pita O; Borradori L; Uter W; Hertl M
Clin Immunol; 2010 Mar; 134(3):320-30. PubMed ID: 20015693
[TBL] [Abstract][Full Text] [Related]
38. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
39. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.
Kricheli D; David M; Frusic-Zlotkin M; Goldsmith D; Rabinov M; Sulkes J; Milner Y
Br J Dermatol; 2000 Aug; 143(2):337-42. PubMed ID: 10951142
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
